CRISPR and Cancer
Cancer Trials
IND Enabling
Phase I
Phase II
Phase III
Advanced Peritoneal Malignancies or Abdominal Metastatic Solid Tumors, (NCT06912152)
Sponsors:
Zhejiang University
Sponsors:
Zhejiang University
IND Enabling
Phase I
Phase II
Phase III
Relapsed or refractory B-cell non-Hodgkin's lymphoma, (NCT06838832)
Sponsors:
Chinese PLA General Hospital
Sponsors:
Chinese PLA General Hospital
IND Enabling
Phase I
Phase II
Phase III
IND Enabling
Phase I
Phase II
Phase III
Relapsed or Refractory T-cell Acute Lymphoblastic Leukaemia, T-ALL, (NCT05509855)
Sponsors:
Wugen, Inc.
Sponsors:
Wugen, Inc.
IND Enabling
Phase I
Phase II
Phase III
Brain, Meninges, and Spinal Cord Metastatic Solid Tumors, (NCT06742593)
Sponsors:
Suzhou Maximum Bio-tech Co., Ltd.
Sponsors:
Suzhou Maximum Bio-tech Co., Ltd.
IND Enabling
Phase I
Phase II
Phase III
Relapsed or refractory B-cell hematological malignancies, (NCT05381181)
Sponsors:
Bioray Laboratories
Sponsors:
Bioray Laboratories
IND Enabling
Phase I
Phase II
Phase III
IND Enabling
Phase I
Phase II
Phase III